Saama
Information
Over 50 biotech companies–including many top 20 pharmaceutical companies–use Saama’s award-winning platform to accelerate over 1,500 studies, including the clinical trial for the world’s first COVID-19 vaccine. LSAC’s rich applications facilitate unprecedented, authoritative oversight and automation of comprehensive clinical research data, enabling companies to file New Drug Applications (NDAs) more efficiently and bring treatments to patients sooner.